[The designs of exploratory biomarker study].

Masahiko Gosho, Kengo Nagashima, Yasunori Sato

Research output: Contribution to journalReview article

Abstract

With the progress of molecular biology and other disciplines, biomarkers are becoming increasingly important in both drug discovery and development. Several critical issues, including scientific rationale, study design, marker assessment, cost and feasibility should be carefully considered in the validation of biomarkers through clinical research. Here, we highlight several important aspects related to the design for clinical researches which incorporate biomarkers. First, we define the term "biomarker" and illustrate the difference between prognostic and predictive markers. Second, in exploratory clinical studies, we focus on issues related to study design for screening and evaluating biomarkers. Finally, we review the design of confirmatory clinical trials for new treatments and companion biomarker diagnostic tests.

Original languageEnglish
Pages (from-to)874-879
Number of pages6
JournalNihon rinsho. Japanese journal of clinical medicine
Volume70
Issue number5
Publication statusPublished - 2012 Jan 1
Externally publishedYes

Fingerprint

Biomarkers
Drug Discovery
Routine Diagnostic Tests
Molecular Biology
Research Design
Clinical Trials
Costs and Cost Analysis
Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

[The designs of exploratory biomarker study]. / Gosho, Masahiko; Nagashima, Kengo; Sato, Yasunori.

In: Nihon rinsho. Japanese journal of clinical medicine, Vol. 70, No. 5, 01.01.2012, p. 874-879.

Research output: Contribution to journalReview article

Gosho, Masahiko ; Nagashima, Kengo ; Sato, Yasunori. / [The designs of exploratory biomarker study]. In: Nihon rinsho. Japanese journal of clinical medicine. 2012 ; Vol. 70, No. 5. pp. 874-879.
@article{e585c9093a7c41a7a82d3a51f1c08011,
title = "[The designs of exploratory biomarker study].",
abstract = "With the progress of molecular biology and other disciplines, biomarkers are becoming increasingly important in both drug discovery and development. Several critical issues, including scientific rationale, study design, marker assessment, cost and feasibility should be carefully considered in the validation of biomarkers through clinical research. Here, we highlight several important aspects related to the design for clinical researches which incorporate biomarkers. First, we define the term {"}biomarker{"} and illustrate the difference between prognostic and predictive markers. Second, in exploratory clinical studies, we focus on issues related to study design for screening and evaluating biomarkers. Finally, we review the design of confirmatory clinical trials for new treatments and companion biomarker diagnostic tests.",
author = "Masahiko Gosho and Kengo Nagashima and Yasunori Sato",
year = "2012",
month = "1",
day = "1",
language = "English",
volume = "70",
pages = "874--879",
journal = "Nihon rinsho. Japanese journal of clinical medicine",
issn = "0047-1852",
publisher = "Nipponrinsho Co., Inc.",
number = "5",

}

TY - JOUR

T1 - [The designs of exploratory biomarker study].

AU - Gosho, Masahiko

AU - Nagashima, Kengo

AU - Sato, Yasunori

PY - 2012/1/1

Y1 - 2012/1/1

N2 - With the progress of molecular biology and other disciplines, biomarkers are becoming increasingly important in both drug discovery and development. Several critical issues, including scientific rationale, study design, marker assessment, cost and feasibility should be carefully considered in the validation of biomarkers through clinical research. Here, we highlight several important aspects related to the design for clinical researches which incorporate biomarkers. First, we define the term "biomarker" and illustrate the difference between prognostic and predictive markers. Second, in exploratory clinical studies, we focus on issues related to study design for screening and evaluating biomarkers. Finally, we review the design of confirmatory clinical trials for new treatments and companion biomarker diagnostic tests.

AB - With the progress of molecular biology and other disciplines, biomarkers are becoming increasingly important in both drug discovery and development. Several critical issues, including scientific rationale, study design, marker assessment, cost and feasibility should be carefully considered in the validation of biomarkers through clinical research. Here, we highlight several important aspects related to the design for clinical researches which incorporate biomarkers. First, we define the term "biomarker" and illustrate the difference between prognostic and predictive markers. Second, in exploratory clinical studies, we focus on issues related to study design for screening and evaluating biomarkers. Finally, we review the design of confirmatory clinical trials for new treatments and companion biomarker diagnostic tests.

UR - http://www.scopus.com/inward/record.url?scp=84864521964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864521964&partnerID=8YFLogxK

M3 - Review article

C2 - 22620016

AN - SCOPUS:84864521964

VL - 70

SP - 874

EP - 879

JO - Nihon rinsho. Japanese journal of clinical medicine

JF - Nihon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 5

ER -